EPSTEIN-BARR VIRUS (EBV) INFECTION
Clinical trials for EPSTEIN-BARR VIRUS (EBV) INFECTION explained in plain language.
Never miss a new study
Get alerted when new EPSTEIN-BARR VIRUS (EBV) INFECTION trials appear
Sign up with your email to follow new studies for EPSTEIN-BARR VIRUS (EBV) INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill takes on Virus-Linked lymphoma in early trial
Disease control Not yet recruitingThis early-phase trial tests an oral drug called VK-2019 in 30 adults with a type of lymphoma (DLBCL) that is linked to the Epstein-Barr virus and has not responded to at least two prior treatments. Participants will take one of three daily doses (600, 1200, or 1800 mg) in 28-day…
Matched conditions: EPSTEIN-BARR VIRUS (EBV) INFECTION
Phase: PHASE1 • Sponsor: Pierluigi Porcu • Aim: Disease control
Last updated Jun 24, 2026 02:34 UTC
-
Could a cancer drug stop a deadly complication in transplant patients?
Prevention Not yet recruitingThis study tests whether the drug rituximab can safely clear Epstein-Barr virus (EBV) from the blood of people who have received a solid organ transplant. High levels of EBV can lead to a serious cancer called post-transplant lymphoproliferative disorder (PTLD). The trial will en…
Matched conditions: EPSTEIN-BARR VIRUS (EBV) INFECTION
Phase: PHASE1 • Sponsor: Jennifer Amengual • Aim: Prevention
Last updated Jun 02, 2026 11:58 UTC